TICKVALE
>⌘K
NYSE · CIK 0001551152 · PHARMACEUTICAL PREPARATIONS

AbbVie Inc.

ABBV chart by TradingView
P/E 70.6xP/B P/SALES 6.9xEV/EBITDA FCF YIELD 4.09%

PRICE HISTORY

LIVE · NYSE
ABBV chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$61.2B
EBITDA
$23.2B
FREE CASH FLOW
$17.8B
EPS
$2.38
GROSS MARGIN
70.24%
ROIC
7.55%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

70.6x
+315%
LATEST · Q2 FY26
70.6xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
13.4x171.8x

P / SALES (TTM)

6.9x
+69%
LATEST · Q2 FY26
6.9xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.3x6.9x

P / BOOK

+1535%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
10.2x261.5x

EV / EBITDA (TTM)

+89%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
10.6x21.5x

EV / REVENUE (TTM)

+59%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.8x7.6x

FCF YIELD (TTM)

4.09%
-2.6pp
LATEST · Q2 FY26
4.09%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
4.09%11.99%

DIVIDEND YIELD (TTM)

2.71%
-0.9pp
LATEST · Q2 FY26
2.71%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.71%3.75%

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$17.0B
+164%
LATEST · Q2 FY26
17.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

$8.3B
+212%
LATEST · Q2 FY26
8.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$3.6B
+126%
LATEST · Q2 FY26
3.6BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$2.04
+109%
LATEST · Q2 FY26
2.04Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

10.16%
+2.0pp
LATEST · Q2 FY26
10.16%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-9.70%59.21%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

18.33%
-2.5pp
LATEST · Q2 FY26
18.33%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
10.49%53.81%

RETURN ON CAPITAL

-33.6pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
5.15%41.19%

RETURN ON EQUITY (TTM)

+201.5pp
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
35.30%295.42%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN74.74%
OPERATING MARGIN37.86%
NET MARGIN21.27%
FCF MARGIN18.33%
89.1356.8124.48-7.84-40.17GROSSOPERNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$3.1B
+132%
LATEST · Q2 FY26
3.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.2B
+141%
LATEST · Q2 FY26
0.2BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.3B
+185%
LATEST · Q2 FY26
0.3BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

1.77B
+8%
LATEST · Q2 FY26
1.77BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$1.73
+204%
LATEST · Q2 FY26
1.73Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$6.6B
+6%
LATEST · Q2 FY26
6.6BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

-4%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

-38%
LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
2.4x4.8x

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 77.14%INSIDERS 0.11%OTHER / RETAIL 22.75%5,178 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.53%150.7M$37.08B-0.3%
Vanguard Capital Management LLC6.50%114.9M$28.27BNEW
State Street Corporation4.60%81.2M$19.98B+0.3%
JPMORGAN CHASE & CO3.21%56.7M$13.96B+8.3%
Vanguard Portfolio Management LLC2.80%49.5M$12.18BNEW
Geode Capital Management, LLC2.65%46.7M$11.50B+4.7%
Morgan Stanley2.15%38.0M$9.35B-5.1%
Capital Research Global Investors1.77%31.3M$7.69B+23.0%
Bank of America Corporation1.35%23.9M$5.89B-7.3%
FMR, LLC1.23%21.8M$5.35B-3.7%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.